Paper39754146
Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.
Zhang J and 15 others. Chin Med, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway. Papers, record 39754146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39754146
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82074284 | The National Natural Science Foundation of China | PubMed | ||
| ZYYCXTD-C-202005-10 | The China National Traditional Chinese Medicine Inheritance and Innovation Team Sub-Project | PubMed | ||
| 2020MZ298-110101 | The China Medical Association of Minorities Research Project | PubMed | ||
| MDK2020013 | The Open Fund Project, Associated Key Laboratory of Traditional Mongolia Medicine Research and Development, National Ethnic Affairs Commission and Ministry of Education of China | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 39930460 | Correction: Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway. | https://conductscience.org/library/papers/39930460 |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36633525 | Cancer statistics, 2023. | CA Cancer J Clin | 2023 | https://conductscience.org/library/papers/36633525 | PubMed |
| 2 | 35143424 | Cancer statistics in China and United States, 2022: profiles, trends, and determinants. | Chin Med J (Engl) | 2022 | https://conductscience.org/library/papers/35143424 | PubMed |
| 3 | 38468501 | [Cancer incidence and mortality in China, 2022]. | Zhonghua Zhong Liu Za Zhi | 2024 | https://conductscience.org/library/papers/38468501 | PubMed |
| 4 | 34273294 | Lung cancer. | Lancet | 2021 | https://conductscience.org/library/papers/34273294 | PubMed |
| 5 | 27188576 | Non-small-cell lung cancer. | Nat Rev Dis Primers | 2015 | https://conductscience.org/library/papers/27188576 | PubMed |
| 6 | 31549028 | Nano-Bio Interactions of Extracellular Vesicles with Gold Nanoislands for Early Cancer Diagnosis. | Research (Wash D C) | 2018 | https://conductscience.org/library/papers/31549028 | PubMed |
| 7 | 31912037 | Tandem Molecular Self-Assembly Selectively Inhibits Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress. | Research (Wash D C) | 2019 | https://conductscience.org/library/papers/31912037 | PubMed |
| 8 | 7521815 | Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. | Chest | 1994 | https://conductscience.org/library/papers/7521815 | PubMed |
| 9 | 11784875 | Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. | N Engl J Med | 2002 | https://conductscience.org/library/papers/11784875 | PubMed |
| 10 | 17473659 | Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China. | J Thorac Oncol | 2007 | https://conductscience.org/library/papers/17473659 | PubMed |
| 11 | 15886310 | Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15886310 | PubMed |
| 12 | 11991792 | The importance of pharmacological synergy in psychoactive herbal medicines. | Altern Med Rev | 2002 | https://conductscience.org/library/papers/11991792 | PubMed |
| 13 | 25535693 | Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. | J Thorac Oncol | 2015 | https://conductscience.org/library/papers/25535693 | PubMed |
| 14 | 30374901 | Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails. | Am J Clin Dermatol | 2018 | https://conductscience.org/library/papers/30374901 | PubMed |
| 15 | 18165622 | Review: side effects of approved molecular targeted therapies in solid cancers. | Oncologist | 2007 | https://conductscience.org/library/papers/18165622 | PubMed |
| 16 | 31601994 | The great escape: tumour cell plasticity in resistance to targeted therapy. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/31601994 | PubMed |
| 17 | 38430032 | Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma. | Cell Mol Biol (Noisy-le-grand) | 2024 | https://conductscience.org/library/papers/38430032 | PubMed |
| 18 | 26203858 | Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT. | Cell Death Dis | 2015 | https://conductscience.org/library/papers/26203858 | PubMed |
| 19 | 22037177 | Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines. | Adv Med Sci | 2011 | https://conductscience.org/library/papers/22037177 | PubMed |
| 20 | 34543169 | Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway. | Pharm Biol | 2021 | https://conductscience.org/library/papers/34543169 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41350419 | Efficacy and safety of AiDi injection in treating primary liver cancer: a systematic review on 70 randomized controlled trials. | Sci Rep | 2025 | https://conductscience.org/library/papers/41350419 | PubMed |
| 41041648 | Cantharidin: a double-edged sword in medicine and toxicology. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41041648 | PubMed |
| 40001110 | Traditional Chinese medicine in lung cancer treatment. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40001110 | PubMed |
| 39930460 | Correction: Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway. | Chin Med | 2025 | https://conductscience.org/library/papers/39930460 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ITGB3 | 3690 | PubTator's text mining | https://conductscience.org/library/genes/3690 | NCBI Gene |
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
| PTK2 | 5747 | PubTator's text mining | https://conductscience.org/library/genes/5747 | NCBI Gene |
| TNC | 3371 | PubTator's text mining | https://conductscience.org/library/genes/3371 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39754146
GET https://conductscience.org/api/papers/v1/39754146/references?page=2